Expression of integrins in bone marrow mesenchymal stem cells derived from patients with chronic myeloid leukemia.
- Author:
Yi-Long LU
1
;
Xian-Qiu YU
;
Yan ZHU
;
Rong BA
;
Wei ZHU
;
Wen-Rong XU
Author Information
1. Department of Hemotology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, Jiangsu Province, China.
- Publication Type:Journal Article
- MeSH:
Adult;
Blast Crisis;
metabolism;
Bone Marrow Cells;
metabolism;
pathology;
Cell Proliferation;
Female;
Humans;
Integrins;
genetics;
metabolism;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive;
metabolism;
pathology;
Male;
Mesenchymal Stromal Cells;
metabolism;
pathology;
Middle Aged;
RNA, Messenger;
genetics;
metabolism;
Tumor Cells, Cultured
- From:
Journal of Experimental Hematology
2008;16(4):755-758
- CountryChina
- Language:Chinese
-
Abstract:
The purpose of this study was to investigate the growth characteristics and the expression level of integrin mRNA of the cultured bone marrow mesenchymal stem cells (BMMSCs) from patients with chronic myeloid leukemia (CML) in myeloid crisis (MC), and explore the role of BMMSCs in pathogenesis of CML. Five CML patients were enrolled in experimental group, five healthy persons were used as control. BMMSCs were cultured in vitro. The morphology of BMMSCs was observed every day and the growth curve were portrayed, and the ability of cell proliferation were detected according to the daily results of cell counting. Total RNA was extracted from third and fourth passages of BMMSCs, The expression of integrins mRNA of BMMSCs were measured by real-time PCR. The results showed that the BMMSCs of experimental and control groups had no difference in growth characterisctics, but the expression of integrins mRNA of the BMMSCs was higher in CML patients than in normal control group (p < 0.05). It is concluded that the abnormally high expression of integrins of BMMSC from the CML patients take part in pathogenesis of CML.
